Why Is Gomekli So Hard to Find? [Explained for 2026]

If you or someone you love has been prescribed Gomekli (mirdametinib) for neurofibromatosis type 1 (NF1), you may have quickly discovered that this medication is not sitting on the shelf at your local pharmacy. Getting Gomekli filled is a different process than picking up a blood pressure medication — and understanding why can save you a lot of frustration.

What Is Gomekli and Why Was It Approved?

Gomekli (mirdametinib) is a MEK inhibitor approved by the FDA on February 11, 2025 for adults and children aged 2 and older with NF1 who have symptomatic plexiform neurofibromas (PN) that cannot be completely removed by surgery. It was developed by SpringWorks Therapeutics and received Priority Review, Fast Track, and Orphan Drug designations — signaling that this is a treatment for a serious, rare condition with limited alternatives.

NF1 affects roughly 1 in 3,000 people, making it one of the more common hereditary neurological disorders — but it's still far less common than conditions like high blood pressure or diabetes. Plexiform neurofibromas, in particular, are tumors that grow along peripheral nerve sheaths and are often impossible to fully remove with surgery due to their infiltrative nature. Gomekli was the first FDA-approved treatment to work for both children and adults with this condition.

Why Is Gomekli Only Available at Specialty Pharmacies?

Gomekli is what the pharmaceutical industry calls a "specialty drug." Specialty drugs are typically high-cost medications used to treat complex, chronic, or rare conditions. They often require special storage, handling, and patient monitoring — and they're distributed through a limited network of specialty pharmacies, not through your average corner drugstore.

SpringWorks Therapeutics distributes Gomekli through a specialty pharmacy and distributor network. This means you cannot walk into a CVS, Walgreens, or Rite Aid and expect to find it. Instead, your prescription will typically be sent by your healthcare provider to a designated specialty pharmacy, which usually ships the medication directly to you.

Does Gomekli Have a Shortage?

As of 2026, Gomekli is not on the FDA's official drug shortage list. However, because it was only approved in February 2025 and treats a rare condition, its distribution network is still maturing. Not every specialty pharmacy has it, and in some regions, access can require navigating multiple steps before the medication arrives at your door.

The biggest barriers most patients face are not supply shortages in the traditional sense — they are access challenges: prior authorization from insurance, enrollment in the specialty pharmacy network, and finding a provider experienced with this medication. These steps can delay treatment even when the drug itself is technically available.

Why Prior Authorization Can Slow You Down

Insurance companies typically require prior authorization (PA) before covering Gomekli. PA criteria usually require documented evidence of NF1 diagnosis, confirmation that symptomatic plexiform neurofibromas are present, and that complete surgical resection is not possible. Your specialist will need to submit clinical documentation supporting all of these criteria.

Because Gomekli is brand-new and treats a rare disease, some insurance utilization management teams may not be fully familiar with the coverage criteria. Appeals or peer-to-peer reviews with an insurance medical director are sometimes required before approval is granted. This process can take days to weeks.

What Are the Main Reasons Patients Struggle to Get Gomekli?

Here's a summary of the most common access hurdles for Gomekli in 2026:

Specialty pharmacy requirement: Not available at retail pharmacies — must be filled through authorized specialty pharmacies.

Prior authorization: Insurance plans almost always require PA, which can take time to obtain.

New drug with limited pharmacy network: Approved in 2025, Gomekli is still being integrated into more specialty pharmacy networks.

Rare disease with few specialists: NF1 specialists such as neuro-oncologists and pediatric neurologists may not be in every region.

High cost: Without financial assistance, Gomekli's annual cost can exceed $100,000, requiring assistance program navigation.

How the SpringWorks CareConnections Program Can Help

SpringWorks Therapeutics offers the SpringWorks CareConnections program specifically to help patients navigate access to Gomekli. The program provides insurance navigation, financial assistance, and dedicated Nurse Advocates who can help coordinate with your specialty pharmacy. Eligible commercial insurance patients may pay as little as $0 per 21-day supply through the copay program, and uninsured or underinsured patients may qualify for the Patient Assistance Program to receive the medication at no cost.

You can reach SpringWorks CareConnections at 844-CARES-55 (844-227-3755), Monday through Friday, 8 AM to 10 PM ET, or visit springworkstxcares.com.

How medfinder Can Help You Find Gomekli

Even for specialty drugs like Gomekli, knowing which pharmacies can actually fill your prescription right now is valuable. medfinder calls pharmacies near you — including specialty pharmacies — to check which ones can fill your prescription, then texts you the results. This takes the guesswork and the phone tag out of the process.

Will Gomekli Become Easier to Get Over Time?

In all likelihood, yes. As SpringWorks Therapeutics scales its distribution network and more insurance plans establish clear coverage policies for Gomekli, the access process should become more streamlined. The European Medicines Agency also issued a positive opinion recommending conditional marketing authorization for Gomekli (as Ezmekly) in May 2025, suggesting growing global recognition of this drug's value.

For now, the best strategy is a combination of working closely with your prescribing specialist, enrolling in SpringWorks CareConnections, and using tools like medfinder to identify which specialty pharmacies in your area have it available. Read our guide on how to find Gomekli in stock near you for step-by-step help.